OPGIX | RSLEX | OPGIX / RSLEX | |
Total Expense Ratio | 1.14 | 1.00 | 114% |
Annual Report Gross Expense Ratio | 1.14 | 1.00 | 114% |
Fund Existence | 35 years | 23 years | - |
Gain YTD | 6.701 | 10.730 | 62% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.4B | 81.3B | 3% |
Annual Yield % from dividends | 0.01 | 0.62 | 1% |
Returns for 1 year | 0.17 | 7.73 | 2% |
Returns for 3 years | 6.96 | 30.28 | 23% |
Returns for 5 years | -27.69 | 13.83 | -200% |
Returns for 10 years | 24.99 | 58.90 | 42% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
VRCA | 5.99 | 0.52 | +9.61% |
Verrica Pharmaceuticals Inc | |||
HALO | 72.21 | 0.39 | +0.54% |
Halozyme Therapeutics | |||
ABLLL | 24.99 | -0.09 | -0.36% |
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028 | |||
OBT | 26.08 | -0.37 | -1.40% |
Orange County Bancorp Inc | |||
COGT | 11.79 | -0.33 | -2.72% |
Cogent Biosciences |